LENZ vs GILD: Which Stock is Better?
Side-by-side comparison of Lenz Therapeutics Inc and Gilead Sciences Inc in 2026
LENZ
Lenz Therapeutics Inc
$10.18
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | LENZ | GILD | Winner |
|---|---|---|---|
| Market Cap | $319.19M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 97.8% | 78.8% | LENZ |
Analyze LENZ
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LENZ or GILD a better investment?
Comparing LENZ and GILD: Lenz Therapeutics Inc has a market cap of $319.19M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LENZ and GILD?
LENZ (Lenz Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LENZ or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LENZ or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for LENZ.
Which company is more profitable: LENZ or GILD?
Lenz Therapeutics Inc (LENZ) has higher gross margins at 97.8% compared to 78.8% for GILD.
Which is the larger company: LENZ or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $319.19M for LENZ.
Should I buy LENZ or GILD in 2026?
Both LENZ and GILD have investment merit. LENZ trades at $10.18 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LENZ and GILD stock?
Key differences: Market Cap ($319.19M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (97.8% vs 78.8%).